Oncology News | Medical Oncologists - ESMO
WEBThe latest daily oncology news for medical oncologists from the European Society for Medical Oncology.
Latest News - ESMO Daily Reporter
WEBLatest News. Stay up-to-date with the latest advances in cancer care by reading our news on studies presented at ESMO congresses and other hot topics in oncology. Filter by: Event. Tumour sites. Topics. Sort by: Date newest to oldest. Cancer in Older Adults.
European Society for Medical Oncology
WEBTumour-agnostic oncology – time has come to re-think clinical research. 27 Aug 2024. Advances in precision oncology are moving the field towards a biology-based cancer care, and ESMO is supporting the change with a series of tailored resources for medical oncologists. Daily Reporter.
ESMO Daily Reporter
WEBLiquid biopsy plays a growing role in early-stage lung cancer. Research is moving forward to understand the value of this blood-based technology as a prognostic tool. 14 Sept 2024. The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society.
Gynaecological Cancers: Immunotherapy and Novel Targeted Drug
WEBSep 14, 2024 · Lugano, Switzerland – Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial (1) and cervical cancers (2) who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a first-in-human study found ‘promising’ antitumour activity with a novel antibody drug conjugate (ADC) targeting the protein claudin 6 in heavily ...
2023 MASCC and ESMO guideline update for the prevention of
WEBJan 11, 2024 · The European Society for Medical Oncology (ESMO) and the Multinational Association of Supportive Care in Cancer (MASCC) completed the fourth Consensus Conference on Antiemetics for the prevention of nausea and vomiting in patients with cancer in Copenhagen in June 2015. …
Studies show immunotherapy improves long-term | EurekAlert!
WEBNews Release 15-Sep-2024. Studies show immunotherapy improves long-term survival in growing number of cancers. Reports and Proceedings. European Society for Medical Oncology. Lugano, Switzerland ...
Tivozanib has efficacy in advanced renal cell carcinoma post …
WEB21 hours ago · reputable news agency ... according to a study published online Sept. 13 in The Lancet to coincide with the annual meeting of the European Society for Medical Oncology, ...
Early data shows mRNA-4359 may benefit patients with ... - News-Medical.net
WEB5 days ago · Results from the Phase I trial, also the first-in-human study of the therapy, are being presented on Saturday, 14 th September at the European Society of Medical Oncology conference in Barcelona ...
Researchers announce clinical trial results for hard-to-treat breast ...
WEB4 days ago · Professors Tom Powles and Peter Schmid recently delivered results from their phase three clinical trials during Sunday's Presidential Symposium to over 30,000 attendees at the European Society for ...